Inflammatory Response Mechanisms in Sepsis

Sepsis arises when an initial infectious insult triggers an aberrant and self-amplifying host response that leads to widespread tissue injury and organ dysfunction. Recognition of pathogen-associated molecular patterns by innate receptors—particularly Toll-like receptor 4 on monocytes, macrophages and endothelial cells—drives a rapid release of pro-inflammatory cytokines such as tumour necrosis factor-α, interleukin-1β and interleukin-6. This ‘cytokine storm’ promotes endothelial activation, increased vascular permeability and coagulation disturbances, culminating in immunothrombosis and microvascular dysfunction. Concurrently, counter-regulatory mechanisms activate anti-inflammatory pathways and regulatory cell subsets, which can overshoot into a state of immunoparalysis characterised by diminished antigen presentation, lymphocyte apoptosis and metabolic reprogramming of leukocytes. The balance between hyperinflammation and immune suppression determines clinical outcome and underlies the heterogeneity of patient trajectories. Sepsis-induced organ injury reflects both collateral damage from uncontrolled inflammation and inadequate pathogen clearance secondary to immune exhaustion. Recent advances reveal that early secondary inflammatory challenges can modulate innate antibacterial capacity and that endogenous mediators may induce tolerance and cross-tolerance via alternative activation of macrophages. Understanding these dual dynamics is essential to developing therapies that restore immune homeostasis without compromising host defence.

Research from Nature Portfolio

In a large-animal intensive care model, early secondary sepsis—elicited by prior endotoxin exposure—was shown to attenuate systemic inflammation yet enhance bacterial clearance in the spleen. This study demonstrated that splenic killing, rather than blood bactericidal capacity alone, correlates with reduced pathogen load when the host has been primed by a mild inflammatory challenge. Such findings challenge the assumption that dampened inflammation uniformly impairs microbial killing and suggest that timing of immunomodulatory interventions could leverage innate resilience.

Investigations into endogenous myeloid-related protein 8 revealed its capacity to induce both self-tolerance and cross-tolerance to diverse bacterial stimuli via Toll-like receptor 4 and 2 pathways. Pre-exposure to this alarmin lowered pro-inflammatory cytokine release while simultaneously enhancing neutrophil recruitment and pathogen clearance in models of polymicrobial sepsis. These insights highlight novel mechanisms by which host-derived mediators calibrate the inflammatory response and offer potential leads for therapeutic modulation.

Inflammatory Response Mechanisms in Sepsis publication trend

The graph below shows the total number of articles in inflammatory response mechanisms in sepsis across all publications each year (not limited to Nature Index journals).

Technical terms

Pathogen-associated molecular pattern (PAMP): Molecular motif from microbes recognised by innate immune receptors.

Toll-like receptor 4 (TLR4): Membrane receptor that detects lipopolysaccharide and initiates pro-inflammatory signalling.

Cytokine storm: Excessive release of pro-inflammatory cytokines leading to systemic inflammation.

Immunoparalysis: State of impaired immune function following initial hyperinflammation.

Endothelial dysfunction: Loss of vascular barrier integrity resulting in tissue oedema and coagulation.

Macrophage polarization: Functional reprogramming of macrophages towards pro-inflammatory (M1) or anti-inflammatory (M2) phenotypes.

Trained immunity: Epigenetic and metabolic reprogramming of innate cells leading to enhanced secondary responses.

References

1. A novel fatty acid analogue triggers CD36–GPR120 interaction and exerts anti-inflammatory action in endotoxemia. Cellular and Molecular Life Sciences (2024).
2. Enhanced bacterial clearance in early secondary sepsis in a porcine intensive care model. Scientific Reports (2023).
3. Sepsis therapies: learning from 30 years of failure of translational research to propose new leads. EMBO Molecular Medicine (2020).
4. TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection. Frontiers in Immunology (2021).
5. Myeloid-related protein 8 induces self-tolerance and cross-tolerance to bacterial infection via TLR4- and TLR2-mediated signal pathways. Scientific Reports (2015).